» Articles » PMID: 32409237

Nomenclature for Kidney Function and Disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference

Abstract

The worldwide burden of kidney disease is rising, but public awareness remains limited, underscoring the need for more effective communication by stakeholders in the kidney health community. Despite this need for clarity, the nomenclature for describing kidney function and disease lacks uniformity. In June 2019, Kidney Disease: Improving Global Outcomes (KDIGO) convened a Consensus Conference with the goal of standardizing and refining the nomenclature used in the English language to describe kidney function and disease, and of developing a glossary that could be used in scientific publications. Guiding principles of the conference were that the revised nomenclature should be patient-centered, precise, and consistent with nomenclature used in the KDIGO guidelines. Conference attendees reached general consensus on the following recommendations: (i) to use "kidney" rather than "renal" or "nephro-" when referring to kidney disease and kidney function; (ii) to use "kidney failure" with appropriate descriptions of presence or absence of symptoms, signs, and treatment, rather than "end-stage kidney disease"; (iii) to use the KDIGO definition and classification of acute kidney diseases and disorders (AKD) and acute kidney injury (AKI), rather than alternative descriptions, to define and classify severity of AKD and AKI; (iv) to use the KDIGO definition and classification of chronic kidney disease (CKD) rather than alternative descriptions to define and classify severity of CKD; and (v) to use specific kidney measures, such as albuminuria or decreased glomerular filtration rate (GFR), rather than "abnormal" or "reduced" kidney function to describe alterations in kidney structure and function. A proposed 5-part glossary contains specific items for which there was general agreement. Conference attendees acknowledged limitations of the recommendations and glossary, but they considered standardization of scientific nomenclature to be essential for improving communication.

Citing Articles

Chronic kidney disease awareness: a cross-sectional study in primary care settings in Türkiye.

Gok E, Sahin M J Nephrol. 2025; .

PMID: 40056272 DOI: 10.1007/s40620-025-02210-y.


Quality matters: chronic kidney disease progression is associated with reduced muscle strength independently of changes in skeletal muscle mass: an observational study.

Chatrenet A, de Mullenheim P, Torreggiani M, Hernandez J, Arronte R, Espinoza A Clin Kidney J. 2025; 18(3):sfaf036.

PMID: 40052163 PMC: 11883232. DOI: 10.1093/ckj/sfaf036.


The landscape of renal protein S-acylation in mice with lipid-induced nephrotoxicity.

Xiu F, Gai Z, Gehrig P, Wolski W, Lone M, Visentin M Sci Rep. 2025; 15(1):7689.

PMID: 40044913 PMC: 11882957. DOI: 10.1038/s41598-025-92530-7.


Influence of Baseline Kidney Function on Patient and Kidney Outcomes in Patients with COVID-19: A Multi-National Observational Study.

Rhee H, Macedo E, Cutter G, Judd E, Parameswaran S, Maccariello E J Clin Med. 2025; 14(4).

PMID: 40004744 PMC: 11856477. DOI: 10.3390/jcm14041212.


CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology.

Zacchia M, Secondulfo F, Melluso A, Del Vecchio Blanco F, Di Iorio V, Torella A Kidney Int Rep. 2025; 10(2):375-385.

PMID: 39990901 PMC: 11843107. DOI: 10.1016/j.ekir.2024.10.030.